S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
S&P 500   3,362.03 (-0.54%)
DOW   29,185.16 (-0.72%)
QQQ   234.00 (-0.27%)
AAPL   317.44 (-2.31%)
FB   217.31 (+1.46%)
MSFT   186.78 (+0.77%)
GOOGL   1,520.84 (+0.14%)
AMZN   2,139.41 (+0.21%)
CGC   22.21 (+0.36%)
NVDA   291.91 (+0.73%)
BABA   218.41 (-0.56%)
MU   57.72 (-1.33%)
GE   12.82 (-0.16%)
TSLA   843.01 (+5.37%)
AMD   56.44 (+2.04%)
T   38.16 (-0.24%)
ACB   1.59 (+0.63%)
NFLX   387.40 (+1.84%)
PRI   135.27 (-1.15%)
BAC   34.24 (-1.75%)
DIS   138.39 (-0.82%)
GILD   67.18 (-0.56%)
Log in

NYSE:EXAM - Examworks Group Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3.56 million shs
Average Volume660,679 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ExamWorks Group, Inc is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
CUSIP30066A10
Phone+1-404-9522400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive EXAM News and Ratings via Email

Sign-up to receive the latest news and ratings for EXAM and its competitors with MarketBeat's FREE daily newsletter.


Examworks Group (NYSE:EXAM) Frequently Asked Questions

What is Examworks Group's stock symbol?

Examworks Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "EXAM."

How were Examworks Group's earnings last quarter?

Examworks Group, Inc. (NYSE:EXAM) announced its quarterly earnings results on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share for the quarter, hitting analysts' consensus estimates of $0.08. The business services provider earned $226.50 million during the quarter, compared to analyst estimates of $217.47 million. Examworks Group's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.05 EPS. View Examworks Group's Earnings History.

Has Examworks Group been receiving favorable news coverage?

News coverage about EXAM stock has been trending extremely negative on Tuesday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Examworks Group earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Examworks Group.

Who are some of Examworks Group's key competitors?

What other stocks do shareholders of Examworks Group own?

What is Examworks Group's official website?

The official website for Examworks Group is http://www.examworks.com/.

How can I contact Examworks Group?

Examworks Group's mailing address is 3280 Peachtree Rd NE Ste 2625, ATLANTA, GA 30305-2457, United States. The business services provider can be reached via phone at +1-404-9522400.


MarketBeat Community Rating for Examworks Group (NYSE EXAM)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  327 (Vote Outperform)
Underperform Votes:  240 (Vote Underperform)
Total Votes:  567
MarketBeat's community ratings are surveys of what our community members think about Examworks Group and other stocks. Vote "Outperform" if you believe EXAM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXAM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Forex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel